A detailed history of Wetherby Asset Management Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Wetherby Asset Management Inc holds 34,053 shares of TAK stock, worth $447,456. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,053
Previous 40,791 16.52%
Holding current value
$447,456
Previous $527,000 8.35%
% of portfolio
0.02%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.0 - $15.08 $87,594 - $101,609
-6,738 Reduced 16.52%
34,053 $483,000
Q2 2024

Aug 14, 2024

SELL
$12.6 - $13.67 $531,808 - $576,969
-42,207 Reduced 50.85%
40,791 $527,000
Q1 2024

May 15, 2024

SELL
$13.89 - $15.04 $52,573 - $56,926
-3,785 Reduced 4.36%
82,998 $1.15 Million
Q4 2023

Feb 14, 2024

SELL
$13.36 - $15.43 $190,179 - $219,646
-14,235 Reduced 14.09%
86,783 $1.24 Million
Q3 2023

Nov 14, 2023

SELL
$15.03 - $16.32 $93,201 - $101,200
-6,201 Reduced 5.78%
101,018 $1.56 Million
Q2 2023

Aug 14, 2023

SELL
$15.57 - $17.11 $81,337 - $89,382
-5,224 Reduced 4.65%
107,219 $1.68 Million
Q1 2023

May 12, 2023

BUY
$15.28 - $16.48 $158,316 - $170,749
10,361 Added 10.15%
112,443 $1.85 Million
Q4 2022

Feb 14, 2023

SELL
$12.42 - $15.62 $16,704 - $21,008
-1,345 Reduced 1.3%
102,082 $1.59 Million
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $172,953 - $387,118
13,512 Added 15.03%
103,427 $1.34 Million
Q2 2022

Aug 15, 2022

SELL
$13.12 - $15.03 $712,311 - $816,008
-54,292 Reduced 37.65%
89,915 $1.26 Million
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $978,698 - $1.11 Million
72,282 Added 100.5%
144,207 $2.07 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $62,373 - $77,670
4,736 Added 7.05%
71,925 $980,000
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $148,313 - $157,048
9,099 Added 15.66%
67,189 $1.1 Million
Q2 2021

Aug 16, 2021

BUY
$16.55 - $18.64 $276,616 - $311,548
16,714 Added 40.4%
58,090 $978,000
Q1 2021

May 14, 2021

SELL
$16.71 - $19.9 $4,077 - $4,855
-244 Reduced 0.59%
41,376 $755,000
Q4 2020

Feb 11, 2021

BUY
$15.39 - $18.97 $575,108 - $708,889
37,369 Added 879.06%
41,620 $757,000
Q3 2020

Dec 16, 2020

SELL
$17.1 - $19.19 $808,060 - $906,823
-47,255 Reduced 91.75%
4,251 $76,000
Q3 2020

Dec 16, 2020

SELL
$17.1 - $19.19 $82,131 - $92,169
-4,803 Reduced 8.53%
51,506 $919,000
Q3 2020

Nov 13, 2020

BUY
$17.1 - $19.19 $117,613 - $131,988
6,878 Added 13.91%
56,309 $1.01 Million
Q2 2020

Aug 14, 2020

BUY
$14.59 - $19.5 $330,200 - $441,324
22,632 Added 84.45%
49,431 $886,000
Q1 2020

May 06, 2020

SELL
$13.02 - $20.31 $215,611 - $336,333
-16,560 Reduced 38.19%
26,799 $407,000
Q4 2019

Jan 28, 2020

BUY
$16.88 - $20.83 $147,632 - $182,179
8,746 Added 25.27%
43,359 $855,000
Q3 2019

Oct 31, 2019

BUY
$16.15 - $17.99 $201,358 - $224,299
12,468 Added 56.3%
34,613 $595,000
Q2 2019

Jul 25, 2019

SELL
$16.58 - $20.49 $209,902 - $259,403
-12,660 Reduced 36.37%
22,145 $392,000
Q1 2019

May 09, 2019

BUY
$16.7 - $21.52 $581,243 - $749,003
34,805 New
34,805 $709,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.9B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.